Int J Clin Rheumatol. 2010;5(4):407-413.

Objectives Patients with SLE take multiple medications. Within a large prospective longitudinal SLE cohort, we characterised ...

Updated specific recommendations are also provided for cutaneous, neuropsychiatric and haematological disease, SLE-associated antiphospholipid syndrome, kidney protection, as well as preventative ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

Connective tissue diseases (CTDs) increase the risk for adverse maternal and fetal outcomes during pregnancy, with varying impacts across different CTD subtypes, according to study results published ...

EULAR/ACR SLE classification criteria were not linked to mortality or hospitalization, a developed ominosity model adequately predicted mortality.

Obinutuzumab is a type II anti-CD20 antibody that results in greater B-cell depletion than rituximab ... Proliferative lupus nephritis (LN) is the most common severe organ-threatening manifestation of ...

Zenas BioPharma, Inc.’s ZBIO share price has surged by 13.37%, which has investors questioning if this is right time to sell.

Lupus can cause hearing loss. This is often due to inflammation or immune responses affecting the inner ear. Symptoms can ...

There are so many different 5-letter words with SLE in them in the English language that might be an answer to a word puzzle or game, and sometimes we need some help narrowing down the options. If you ...

Jan. 21, 2025 — Researchers identified a key protein as a potential therapeutic target for stopping the body's immune system from mistakenly attacking itself, offering new hope for treating ...

SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to ...